The internal and external impacts of the Clinical Trials Network: A view from a longitudinal platform study.

This poster provides an overview of ten years of findings from the University of Georgia’s longitudinal platform study of the CTN. The study has shown a greater adoption of evidence-based practices (EBPs) in CTN-affiliated community-based treatment programs (CTPs) than in non-CTPs. CTN-affiliated counselors also hold more favorable attitudes towards EBPs than their non-CTN-affiliated counterparts.

In this poster, the specific EBPs addressed include buprenorphine, motivational incentives, and tablet naltrexone and acamprosate. The findings demonstrate the importance of a research network in promoting adoption of EBPs and fostering a higher level of receptivity to innovation adoption in general. The CTN is fulfilling its goal of increasing the quality of treatment within its constituent CTPs; future research should examine the extent to which programs are using these interventions in everyday treatment practice and assess the fidelity with which these practices are being implemented.

Categories: Acamprosate, Adoption of interventions, Attitudes of health personnel, Behavior therapy, Buprenorphine, Community health services, CTN platform/ancillary study, Evidence-based treatment, Motivational incentives, National Treatment Center Study (NTCS), Pharmacological therapy
Tags: Poster
Authors: Roman, Paul M.; Abraham, Amanda J.; Knudsen, Hannah K.; Ducharme, Lori J.; Rothrauff, Tanja C.; Savage, Sarah A.
Source: Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010